USFDA gives approval to Alembic Pharma for Arformoterol Tartrate Inhalation Solution

rformoterol Tartarate Inhalation Solution is a long-acting beta2-adrenergic agonist (beta2-agonist) indicated for long-term

79
USFDA
Picture: Pixabay

Last Updated on May 14, 2022 by The Health Master

Alembic Pharma today announced that it has received final approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Arformoterol Tartrate Inhalation Solution, 15 mcg (base)/2 mL unit-dose vial.

The approved ANDA is therapeutically equivalent to the Reference Listed Drug (RLD) product Brovana Inhalation Solution, 15 mcg/2 mL, of Sunovion Pharma, Alembic Pharma said in a statement.

Arformoterol Tartarate Inhalation Solution is a long-acting beta2-adrenergic agonist (beta2-agonist) indicated for long-term, twice daily (morning and evening) administration in the maintenance treatment of bronchoconstriction in patients with Chronic Obstructive Pulmonary Disease (COPD), including chronic bronchitis and emphysema, the statement added.

It also said that this ANDA has been co-developed in partnership with Orbicular Pharma.

USFDA gives nod to Alembic for this generic solution for Inhalation

USFDA gives approval to Alembic Pharma for Arformoterol Tartrate Inhalation Solution

USFDA gives tentative nod to Glenmark for Calcipotriene and Betamethasone Dipropionate foam

USFDA gives tentative approval for this Hypertension drug

USFDA gives tentative nod to Zydus for Selexipag tablets

USFDA gives approval to Lupin Pregabalin capsules

NPPA fixes Retail Price of 84 formulations: May 2022

NPPA fixes retail price of Emcure’s HIV drug combination

USFDA gives nod to Alembic for this generic solution for Inhalation

USFDA gives 10 observations to Sun Pharm

CDSCO extends timeline for importing of drugs with shelf life less than 60%

FAQs – on Blood Bags and its Testing

USFDA gives tentative nod to Glenmark for Calcipotriene and Betamethasone Dipropionate foam

IPC releases IP 2022, 92 new monograph, 27 APIs added: Read details

USFDA gives tentative approval for this Hypertension drug

Latest Notifications regarding Pharmaceuticals

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news

Enter your email address:

Delivered by FeedBurner